«ANGIOLINE» took part in the international congress EuroPCR 2019 in Paris
The «Angioline» company took part in the congress EuroPCR 2019 which took place in Paris on May 21-24. This event is annually held by the European association on transdermal coronary interventions (EAPCI) and is the leading platform for exchange of experience between specialists in the field of intervention cardiology from around the world: every year about 11 thousand people become participants of the congress. Within EuroPCR «Angioline» presented one of the developments at an exhibition – the transcatheter aortal valve of heart with the system of delivery. Visitors of the stand had an opportunity to get acquainted closer with the device, to independently install the valve in the working model of heart and vessels, to estimate the user properties of future product. Let's note that «Angioline» actively advances the products not only in Russia, but also in the world market. Today export is carried out to the CIS countries, the Republic of Vietnam. The quality of products is confirmed by certificates in the international ISO standards. In plans of the company ― obtaining the CE mark and entry into the European markets.